Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-34422074

ABSTRACT

BACKGROUND: Alzheimer's disease is a neurological condition that affects about 44 million people worldwide. The available treatments target symptoms rather than the underlying causes. Ziziphus jujuba (Rhamnaceae) is widely used in traditional Cameroonian medicine to treat diabetes, pain, infections, and dementia. Previous studies reported that Z. jujuba aqueous macerate improves working memory impairment, but no study on the antiamnesic effect of a concoction of Z. jujuba in rats has been performed. Therefore, this study aimed to assess the antiamnesic and neuroprotective effects of an aqueous extract of Z. jujuba on scopolamine-induced cognitive impairments in rats. METHODS: Learning and memory impairments were induced in rats by administering scopolamine (1 mg/kg, i.p.) to 58 rats for 15 days. Rats that developed learning and memory impairments in Morris water maze and Y-maze paradigms were divided into 7 groups (8 rats each) and treated daily for 15 days as follows: the normal control group received distilled water (10 ml/kg, p.o.), the negative control group received distilled water (10 ml/kg, p.o.), positive control groups either received donepezil (1.2 mg/kg, p.o.) or tacrine (10 mg/kg, p.o.), and the three test groups were given the extract (29, 57, and 114 mg/kg, p.o.). At the end of treatments, learning and memory impairments were determined using the same paradigms. Animals were then euthanized, and biochemical parameters of oxidative stress, inflammation, and apoptosis were analyzed in the hippocampus and prefrontal cortex. RESULTS: On the 4th day of the acquisition phase in the Morris water maze, Z. jujuba (29 and 114 mg/kg) reduced (p < 0.001) the latency to reach the platform, while in the retention phase, Z. jujuba (57 and 114 mg/kg) decreased (p < 0.001) the time to reach the platform and increased the time in the target quadrant (p < 0.05) compared to control. Surprisingly, the extract failed to affect spontaneous alternations in the Y-maze. Furthermore, the extract (29, 57, and 114 mg/kg) reversed (p < 0.001) scopolamine-induced oxidative stress, inflammation, and apoptosis. This was supported by the reduction of neuronal alterations in the hippocampus and prefrontal cortex. CONCLUSIONS: Compared to donepezil, a standard drug against Alzheimer's disease, these findings suggest that Z. jujuba extract possesses antiamnesic and neuroprotective effects, and these effects are mediated in part through antioxidant, anti-inflammatory, and antiapoptotic activities. These findings help to explain its use in treating psychiatric disorders in Cameroon's folk medicine.

2.
Front Pharmacol ; 10: 952, 2019.
Article in English | MEDLINE | ID: mdl-31551770

ABSTRACT

Over the last decade, several studies demonstrated that prenylation of flavonoids enhances various biological activities as compared to the respective nonprenylated compounds. In line with this, the natural prenylated isoflavonoid alpinumisoflavone (AIF) has been explored for a number of biological and pharmacological effects (therapeutic potential). In this review, we summarize the current information on health-promoting properties of AIF. Reported data evidenced that AIF has a multitherapeutic potential with antiosteoporotic, antioxidant and anti-inflammatory, antimicrobial, anticancer, estrogenic and antiestrogenic, antidiabetic, and neuroprotective properties. However, research on these aspects of AIF is not sufficient and needs to be reevaluated using more appropriate methods and methodology. Further series of studies are needed to confirm these pharmacological effects, and this review should lay the basis for the design of respective investigations. Overall, despite the drawbacks of studies recorded, AIF exhibits a potential as drug candidate.

3.
Behav Neurol ; 2018: 5751864, 2018.
Article in English | MEDLINE | ID: mdl-30363978

ABSTRACT

The present work was undertaken to evaluate the ability of F. umbellata aqueous extract and its major component 7-methoxycoumarin (MC) to improve scopolamine-induced spatial memory impairment in ovariectomized Wistar rats. For this to be done, 10 sham-operated and 30 postmenopausal-like rats were randomly distributed in eight groups (n = 5) and treated with distilled water (2 mL/250 g), estradiol valerate (1 mg/kg BW), piracetam (1.5 mg/kg BW), F. umbellata aqueous extract (50 and 200 mg/kg BW), or MC (1 mg/kg BW) for 21 consecutive days. Before and after the memory impairment with scopolamine (2 mg/kg BW), animals underwent behavioral evaluations on Y- and radial mazes. As results, age and ovariectomy did not induce significant changes in the reference memory errors. While age decreased working memory errors, ovariectomy increased it. The MC as well as F. umbellata extract significantly increased (p < 0.01) the percentage of spontaneous alternation and decreased (p < 0.001) working and spatial reference memory errors and anxiety parameters (rearing and grooming) in ovariectomized rats. MC significantly reduced (p < 0.05) the MDA level, but resulted in an increase in GSH level in brain homogenates. These results suggest that MC is endowed with neuroprotective effects and could account for the neuroprotective effects of F. umbellata in rats.


Subject(s)
Memory, Short-Term/drug effects , Spatial Memory/drug effects , Umbelliferones/pharmacology , Animals , Female , Ficus/chemistry , Ficus/metabolism , Maze Learning/drug effects , Memory Disorders/chemically induced , Moraceae , Neuroprotective Agents/pharmacology , Ovariectomy/psychology , Plant Extracts/pharmacology , Rats , Rats, Wistar , Scopolamine , Spatial Memory/physiology
4.
PLoS One ; 13(8): e0202271, 2018.
Article in English | MEDLINE | ID: mdl-30153255

ABSTRACT

BACKGROUND: Hydroquinone-containing creams cause false increases in capillary glycemia. However, the magnitude of this false increase, and the means to reverse it have not been investigated. OBJECTIVE: To evaluate the technical and clinical impact of hydroquinone-containing creams on capillary glycemia and investigate the efficacy of hand washing and other common practices, in reversing cream effects. METHODS: We included 91 participants in a quasi-experimental study in Buea, Cameroon. After determining the hydroquinone content of a cream, Caro Light, we used two glucometers with different enzymatic systems (Accu-Chek Active and OneTouch Ultra 2) to measure fasting glycemia after: initial hand washing (reference), application of 1 ml of hydroquinone-containing cream, finger swabbing with wet gauze, sanitizer application and a series of three hand washings following cream application. Reference glycemia was compared to those obtained after various interventions. Statistical significance was assessed by paired sample t-test, clinical significance by total error allowable (TEa), and clinical impact by Parke's error grid analysis. RESULTS: The mean differences in capillary glycemia (Intervention-reference) measured by Accu-Chek Active in mg/dl were 28, 27, 38, 16, 4, and -2 after cream application, finger swabbing, sanitizer application, one, two, and three hand washings respectively. Corresponding values for OneTouch Ultra2 were 41, 44, 64, 22, 5 and -5. These differences, except after two and three hand washings were both statistically (p < 0.0001) and clinically significant (TEa). After cream application, Accu-Check had 9.9% of values in Parke's Zones C-E, while OneTouch had 18.7%. CONCLUSION: Hydroquinone-containing creams cause significant false increase in capillary glycemia irrespective of the enzymatic system of the glucometer used, and can lead to potentially wrong clinical decisions. A minimum of two hand washings is required prior to capillary glucose measurement.


Subject(s)
Blood Glucose/drug effects , Capillaries/drug effects , Hand Disinfection , Hydroquinones/administration & dosage , Skin Cream , Adult , Aged , Blood Glucose Self-Monitoring , Cameroon , Capillaries/metabolism , Diabetes Mellitus/blood , Female , Humans , Male , Middle Aged , Time Factors , Young Adult
5.
Behav Brain Funct ; 14(1): 14, 2018 Jul 16.
Article in English | MEDLINE | ID: mdl-30012162

ABSTRACT

BACKGROUND: Estrogen deficiency is linked to changes in several physiological processes, but the extent to which it associates with cognitive changes in menopause context is controversial. RATIONALE: We evaluated the impact of ovariectomy on memory processes and normal exploratory behavior in Wistar rats. METHODS: Young adult rats (4-6 months) were either ovariectomized (OVX group) (N = 10), sham operated (N = 10), or untouched (naïve controls) (N = 8). Afterwards, they were monitored for 12 weeks during which their cognitive functions were evaluated at first week (S1), second (S2), every 3 weeks (S5, S8) and then at week 12 (S12) using: (i) object recognition test to evaluate the short-term and long-term non-spatial memory; (ii) the object placement test to assess the spatial memory; and (iii) normal exploratory behavior components like locomotor and vertical activities in an open field arena. RESULTS: Marked changes in ovariectomized rats were observed in long-term non-spatial memory (~ 40% change vs. naïve and sham, P < 0.001) and spatial memory (~ 30% change, P < 0.05) from S2. Instead, from S5 the exploratory behavior was affected, with decreases in line crossing and rearing episode numbers (~ 40% change, P < 0.01), and in the time spent in the center of open field arena (~ 60% change, P < 0.01). CONCLUSIONS: Our findings support the involvement of sex hormones in cognitive functions in female rats and suggest that controversy on the importance of cognitive affections in menopause context may emerge from differences between short-term and long-term memory processes.


Subject(s)
Exploratory Behavior/physiology , Locomotion/physiology , Memory Disorders/psychology , Ovariectomy/adverse effects , Spatial Memory/physiology , Animals , Female , Maze Learning/physiology , Memory Disorders/etiology , Memory Disorders/metabolism , Ovariectomy/trends , Random Allocation , Rats , Rats, Wistar , Recognition, Psychology/physiology
6.
Medicines (Basel) ; 5(3)2018 Jul 07.
Article in English | MEDLINE | ID: mdl-29986496

ABSTRACT

Background: Despite the wide use of leaves of Myrianthus arboreus (Cecropiaceae) in several African countries including Cameroon as food and against amenorrhea and female infertility, it has never been tested for this purpose. Methods: Using immature female Wistar rats, the impact of M. arboreus on the sexual maturation parameters (vaginal opening, ovarian relative weight and follicle maturation, gonadotropins and ovarian hormones serum levels) and fertility index has been evaluated through a 30-day oral administration of aqueous and methanol extracts of leaves at the doses of 20, 110 and 200 g/kg/day. Results: Aqueous extract increased the ovarian relative weight (p < 0.001), progesterone (p < 0.001) and gonadotropins (p < 0.001) serum levels, and induced the maturation of ovarian follicles. The methanol extract additionally induced an early vaginal opening (p < 0.001), uterine growth (p < 0.01) and increased estradiol (p < 0.001) serum levels. The fertility index generally increased following treatments, while the gestation rate remained almost unaffected except at the highest tested dose of M. arboreus extracts where lowest values were observed. Conclusion: Globally, M. arboreus induced an early puberty onset and an increased fertility rate validating at least in part its traditional use for female infertility.

7.
J Ethnopharmacol ; 179: 332-44, 2016 Feb 17.
Article in English | MEDLINE | ID: mdl-26771069

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Ficus umbellata Vahl. (Moraceae) is a medicinal plant used in Cameroon to treat amenorrhea as well as other physiological disorders related to menopause. AIM OF STUDY: In order to justify scientifically its traditional use, the estrogen-like properties of the aqueous (AE) and methanol (MeOH) extracts of F. umbellata were investigated. MATERIAL AND METHODS: In vitro, the ability of different extracts of F. umbellata to activate estrogen receptors α (ERα) and ß (ERß) in cell-based reporter gene assays using human embryonic kidney (HEK293T) cells transfected with ERs was tested. In vivo, a 3-day uterotrophic assay and the capacity of the extracts to alleviate hot flushes in ovariectomized adult rats were tested. Using a bioassay-guided fractionation the major compound of F. umbellata was isolated and tested in vitro on HEK293T-ERα and ERß cells. RESULTS: AE and MeOH extracts significantly altered ERα as well as ERß activities. In vivo, both extracts significantly increase the uterine and vaginal epithelium thickness, and uterine total protein levels in a dose dependent manner. Interestingly, both extracts of F. umbellata at the dose of 100 mg/kg BW significantly decreased the total number, average duration as well as frequency of hot flushes in experimental rats compared to age-matched OVX controls. Finally, 7-methylumbelliferone, a coumarin was characterized as the major compound of F. umbellata; however this compound did not transactivate ERα as well ERß in vitro. CONCLUSION: These aforementioned results suggest that F. umbellata extracts as used by the traditional practitioner have estrogen-like effects and may alleviate some menopausal problems such as vaginal dryness and hot flushes.


Subject(s)
Estrogens/therapeutic use , Ficus/chemistry , Menopause/drug effects , Ovariectomy/adverse effects , Plant Extracts/therapeutic use , Animals , Cell Survival/drug effects , Cells, Cultured , Epithelium/drug effects , Estrogens/adverse effects , Estrogens/pharmacology , Female , Hot Flashes/drug therapy , Humans , Mammary Glands, Human/drug effects , Organ Size/drug effects , Plant Extracts/adverse effects , Plant Extracts/chemistry , Plant Extracts/pharmacology , Proteins/metabolism , Rats , Rats, Wistar , Receptors, Estrogen/metabolism , Umbelliferones/pharmacology , Uterus/drug effects , Uterus/metabolism , Vagina/drug effects
8.
J Ethnopharmacol ; 176: 494-8, 2015 Dec 24.
Article in English | MEDLINE | ID: mdl-26602454

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Dichrocephala integrifolia (Asteraceae) is commonly used in the folk medicine in Cameroon to treat various ailments including headaches, jaundice, filariasis, neuritis and children's night agitation. It is also known to have anxiolytic properties. Since there were no scientific data supporting the above claims, we therefore aimed to evaluate the anxiolytic and sedative effects of the aqueous leaf extract of D. integrifolia. MATERIALS AND METHODS: The extract used was obtained after maceration of leaves of D. integrifolia in water at room temperature. The anxiolytic effect was tested by the elevated plus-maze (EPM) and Open Field tests while the sedative effect was evaluated by the diazepam-induced sleep test. RESULTS: D. integrifolia significantly induced an increase in the percentage of entries into open arms and a decrease in percentage of entries into closed arms at the dose of 22 mg/kg BW. The extract also induced a decrease of rearing and head dipping at the doses of 22 and 40 mg/kg BW during the EPM test. In addition, D. integrifolia extract induced a significant increase of crossing and time spent at the center of the experimental set at the dose of 40 mg/kg BW during the open field test. Lastly, D. integrifolia caused a significant reduction of the latency to sleep and an increase of total sleep time at the doses of 22 and 40 mg/kg BW in the diazepam-induced sleep test. CONCLUSION: The results obtained in this study suggest that the aqueous leaf extract of D. integrifolia is endowed with anxiolytic and sedative properties, which justify its traditional use.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety/drug therapy , Asteraceae , Hypnotics and Sedatives/therapeutic use , Plant Extracts/therapeutic use , Sleep/drug effects , Animals , Behavior, Animal/drug effects , Diazepam , Male , Medicine, African Traditional , Mice , Phytotherapy , Plant Leaves
9.
J Complement Integr Med ; 12(4): 283-7, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26214610

ABSTRACT

BACKGROUND: Newtonia griffoniana (Mimosaceae) is a Central African rain forest tree, whose bark extracts are used in Cameroonian folk medicine for the treatment of anxiety and sleep disorders. METHODS: We evaluated the anxiolytic effects of N. griffoniana stem bark methanol extract and its major isolated constituent 2,3,4-trihydroxybutylpentatriacontanoate (newtonoate) on the elevated plus maze. RESULTS: Significant increases in the percentage of entries into open arms were induced by both N. griffoniana extract (100 and 150 mg/kg BW; p<0.01) and newtonoate (doses of 3 and 15 mg/kg BW; p<0.05). Conversely, decreases in the percentage of entries into closed arms were observed at the same doses. In addition, N. griffoniana methanol extract (100 mg/kg) and the isolated newtonoate (30 mg/kg) induced significant (p<0.01 and p<0.05, respectively) increases in the time spent in the open arms, while inducing a decrease in the time spent in the closed arms. Newtonoate treatment also decreased head dipping number at doses of 3 and 15 mg/kg, while N. griffoniana methanol extract induced the same effect at 200 mg/kg. CONCLUSIONS: These results suggest that N. griffoniana bark extract has anxiolytic properties, which justify its use in folk medicine. Such effects are at least partly mediated by newtonoate.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety/drug therapy , Fabaceae/chemistry , Fatty Acids/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Animals , Anti-Anxiety Agents/pharmacology , Behavior, Animal , Cameroon , Fatty Acids/pharmacology , Male , Maze Learning , Medicine, African Traditional , Mice , Plant Bark , Plant Extracts/pharmacology , Plant Stems
10.
Planta Med ; 81(14): 1263-9, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26166135

ABSTRACT

Oleocanthal is a bioactive compound from olive oil. It has attracted considerable attention as it is anti-inflammatory, antiproliferative, and has been shown to possess neuroprotective properties in vitro and in vivo. Delineated from its polyphenolic structure, the aim of this study was to characterize oleocanthal towards estrogenic properties. This might contribute to partly explain the beneficial effects described for the Mediterranean diet. Estrogenic properties of oleocanthal were assessed by different methods: a) stimulation of reporter gene activity in MVLN or RNDA cells either expressing estrogen receptor α or ß, b) stimulation of luciferase reporter gene activity in U2OS osteosarcoma cells expressing estrogen receptor α or ß, and c) elucidation of the impact on estradiol-induced gene expression in U2OS cells transduced with both estrogen receptors. Depending on the cell line origin, oleocanthal inhibited luciferase activity (MVLN, U2OS-estrogen receptor ß) or weakly induced reporter gene activity at 10 µM in U2OS-estrogen receptor α cells. However, oleocanthal inhibited stimulation of luciferase activity by estradiol from both estrogen receptors. Oleocanthal, if given alone, did not stimulate gene expression in U2OS cells, but it significantly modulated the response of estradiol. Oleocanthal enhanced the effect of estradiol on the regulation of those genes, which are believed to be regulated through heterodimeric estrogen receptors. As the estrogenic response pattern of oleocanthal is rather unique, we compared the results obtained with oleacein. Oleocanthal binds to both estrogen receptors inducing estradiol-agonistic or antiagonistic effects depending on the cell line. Regarding regulation of gene expression in U2OS-estrogen receptor α/ß cells, oleocanthal and oleacein enhanced estradiol-mediated regulation of heterodimer-regulated genes.


Subject(s)
Aldehydes/pharmacology , Estradiol/pharmacology , Estrogen Receptor alpha/genetics , Gene Expression Regulation/drug effects , Phenols/pharmacology , Selective Estrogen Receptor Modulators/pharmacology , Aromatase/genetics , Cell Line/drug effects , Cyclopentane Monoterpenes , Dose-Response Relationship, Drug , Estrogen Receptor beta/genetics , Genes, Reporter , Humans , Phosphoric Diester Hydrolases/genetics , Response Elements/drug effects , Response Elements/genetics , von Willebrand Factor/genetics
11.
Planta Med ; 80(11): 861-9, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25116117

ABSTRACT

Erythrina poeppigiana is a medicinal plant which is widely used in Asia, Latin America, and Africa in traditional remedies for gynecological complications and maladies. In continuation of studies for the discovery of novel phytoestrogens, four erythroidine alkaloids, namely α-erythroidine, ß-erythroidine, and their oxo-derivatives 8-oxo-α-erythroidine and 8-oxo-ß-erythroidine, were isolated and structurally characterized from the methanolic extract of the stem bark of E. poeppigiana. Due to the high amounts of erythroidines in the extract and considering the widespread utilization of Erythrina preparations in traditional medicine, the exploration of their estrogenic properties was performed. The estrogenicity of the isolated erythroidines was assayed in various estrogen receptor-(ER)-dependent test systems, including receptor binding affinity, cell culture based ER-dependent reporter gene assays, and gene expression studies in cultured cells using reverse transcription polymerase chain reaction techniques. α-Erythroidine and ß-erythroidine showed binding affinity values for ERα of 0.015 ± 0.010% and 0.005 ± 0.010%, respectively, whereas only ß-erythroidine bound to ERß (0.006 ± 0.010%). In reporter gene assays, both erythroidines exhibited a significant dose-dependent estrogenic stimulation of ER-dependent reporter gene activity in osteosarcoma cells detectable already at 10 nM. Results were confirmed in the MVLN cells, a bioluminescent variant of MCF-7 breast cancer cells. Further, α-erythroidine and ß-erythroidine both induced the enhanced expression of the specific ERα-dependent genes trefoil factor-1 and serum/glucocorticoid regulated kinase 3 in MCF-7 cells, confirming estrogenicity. Additionally, using molecular docking simulations, a potential mode of binding on ERα, is proposed, supporting the experimental evidences. This is the first time that an estrogenic profile is reported for erythroidine alkaloids, potentially a new class of phytoestrogens.


Subject(s)
Alkaloids/isolation & purification , Erythrina/chemistry , Phytoestrogens/isolation & purification , Plant Extracts/isolation & purification , Alkaloids/chemistry , Alkaloids/pharmacology , Cell Line , Dihydro-beta-Erythroidine/chemistry , Dihydro-beta-Erythroidine/isolation & purification , Dihydro-beta-Erythroidine/pharmacology , Estrogen Receptor alpha/drug effects , Estrogen Receptor beta/drug effects , Genes, Reporter , Humans , Molecular Structure , Phytoestrogens/chemistry , Phytoestrogens/pharmacology , Plant Bark/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Stems/chemistry , Plants, Medicinal , Recombinant Proteins
12.
J Complement Integr Med ; 102013 Aug 22.
Article in English | MEDLINE | ID: mdl-23969473

ABSTRACT

In developing countries, around 80% of the population still resorts on traditional medicine for their primary health care. Erythrina poeppigiana (Walp.) O.F. Cook, one of these medicinal plants, was found to be particularly rich in isoflavonoids which exhibited, individually, significant estrogenic activity in vitro. The possible combined effects of these bioactive isoflavones, as they are naturally found in the crude extracts of E. poeppigiana, prompted us to assess their in vivo estrogenicity. We first tested the ability of the extracts to transactivate estrogen receptor alpha (ERα) in vitro using U2OS human osteosarcoma cells. We next investigated their effects in vivo in an uterotrophic assay, using ovariectomized rats treated with the extracts at the doses of 50, 100, 200, and 400 mg/kg BW/d orally for 3 days. Finally, we assessed their ability to relieve hot flushes, using data loggers. At the end of treatments, animals were sacrificed, and organs (mammary glands, vagina, and uteri) were collected for histo-morphometric analyses. The methanol extract significantly and dose-dependently transactivated ERα at all tested doses. All extracts induced significant increases of vaginal and uterine epithelial heights. Only the dichloromethane extract could significantly relieve hot flushes as estradiol. These results indicate that E. poeppigiana extracts have estrogen-like effects in vivo, suggesting that its active principles act in synergy when they are taken in combination in the crude extract. These findings, therefore, support the traditional use of E. poeppigiana to alleviate some menopausal problems; our previous phytochemical investigations contribute to the standardization of this phytomedicine.


Subject(s)
Erythrina/chemistry , Estrogen Receptor alpha/metabolism , Hot Flashes/drug therapy , Isoflavones/pharmacology , Phytoestrogens/pharmacology , Phytotherapy , Plant Extracts/pharmacology , Animals , Cell Line , Dose-Response Relationship, Drug , Female , Hot Flashes/metabolism , Humans , Isoflavones/therapeutic use , Ovariectomy , Phytoestrogens/therapeutic use , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Rats , Rats, Wistar
13.
Planta Med ; 79(7): 600-11, 2013 May.
Article in English | MEDLINE | ID: mdl-23539352

ABSTRACT

Approximately 80 % of the population in Africa use traditional medicinal plants to improve their state of health. The reason of such a wide use of medicinal plants has been mainly attributed to their accessibility and affordability. Expectation of little if any side effects, of a "natural" and therefore safe treatment regimen, as well as traditional beliefs additionally contribute to their popularity. Several of these plants are used by women to relieve problems related to their reproductive health, during or after their reproductive life, during pregnancy, or following parturition. The African pharmacopoeia thus provides plants used for preventing and/or treating gynecological infections, dysmenorrhea, irregular menstruations, oligomenorrhea or protracted menstruation, and infertility. Such plants may then be used as antimicrobians, emmenagogues, or as suppressors of uterine flow. African medicinal plants are also used during pregnancy for prenatal care, against fetal malposition or malpresentation, retained dead fetus, and against threatened abortion. Some others are used as anti-fertilizing drugs for birth control. Such plants may exert various activities, namely, anti-implantation or early abortifacient, anti-zygotic, blastocytotoxic, and anti-ovulatory effects. Some herbs could also act as sexual drive suppressors or as a post-coital contraceptive by reducing the fertility index. A number of these plants have already been subject to scientific investigations and many of their properties have been assessed as estrogenic, oxytocic, or anti-implantation. Taking into account the diversity of the African pharmacopoeia, we are still at an early stage in the phytochemical and pharmacological characterization of these medicinal plants that affect the female reproductive system, in order to determine, through in vitro and in vivo studies, their pharmacological properties and their active principles.


Subject(s)
Female Urogenital Diseases/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Plants, Medicinal , Pregnancy Complications/prevention & control , Reproductive Health , Women's Health , Cameroon , Female , Humans , Plant Extracts/pharmacology , Pregnancy , Pregnancy Complications/drug therapy
14.
Endocr Relat Cancer ; 20(1): R1-R17, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23207292

ABSTRACT

Insulin, IGF1, and IGF2 are the most studied insulin-like peptides (ILPs). These are evolutionary conserved factors well known as key regulators of energy metabolism and growth, with crucial roles in insulin resistance-related metabolic disorders such as obesity, diseases like type 2 diabetes mellitus, as well as associated immune deregulations. A growing body of evidence suggests that insulin and IGF1 receptors mediate their effects on regulating cell proliferation, differentiation, apoptosis, glucose transport, and energy metabolism by signaling downstream through insulin receptor substrate molecules and thus play a pivotal role in cell fate determination. Despite the emerging evidence from epidemiological studies on the possible relationship between insulin resistance and cancer, our understanding on the cellular and molecular mechanisms that might account for this relationship remains incompletely understood. The involvement of IGFs in carcinogenesis is attributed to their role in linking high energy intake, increased cell proliferation, and suppression of apoptosis to cancer risks, which has been proposed as the key mechanism bridging insulin resistance and cancer. The present review summarizes and discusses evidence highlighting recent advances in our understanding on the role of ILPs as the link between insulin resistance and cancer and between immune deregulation and cancer in obesity, as well as those areas where there remains a paucity of data. It is anticipated that issues discussed in this paper will also recover new therapeutic targets that can assist in diagnostic screening and novel approaches to controlling tumor development.


Subject(s)
Insulin Resistance , Insulin/metabolism , Neoplasms/etiology , Somatomedins/metabolism , Animals , Energy Metabolism , Humans , Neoplasms/metabolism , Neoplasms/pathology , Signal Transduction
15.
J Steroid Biochem Mol Biol ; 120(4-5): 184-91, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20420908

ABSTRACT

Eight isoflavones derivatives, with isoprenyl and/or 7-methoxy substitution, isolated from Erythrina poeppigiana (Fabaceae) have been investigated for their estrogenic properties in receptor subtype-specific reporter gene assays. First we focused on their estrogen receptor alpha and beta (ERalpha and ERbeta) selectivity, second we addressed structure-activity relationships, using bone-derived human osteosarcoma cell line (U2OS cells) stably expressing ERalpha or transiently expressing ERbeta. Our results show that a substitution at position 3' together with a 7-methoxy substitution on the genistein skeleton is associated with a statistically significant activation of the ERalpha- and ERbeta-dependent reporter gene expression in U2OS cells starting from 0.1nM. Particularly, the 7-methoxy-3'-isoprenyl (1) and the 7-methoxy-3'-(3-methyl-2-hydroxybuten-3-yl) (3) derivatives of genistein induces an ERalpha- and ERbeta-coupled luciferase activity at a concentration ten times lower than that of genistein, for which a statistically significant effect was observable at 1nM. On the other hand, isoprenyl substitution at position 6 of the A ring, compound 5, seems to have very little impact on the genistein ability to induce ER-coupled luciferase activity in U2OS cells, while a double prenylation at positions 8 and 3', compound 7, is associated with an almost complete loss of function on the reporter gene activation in U2OS-ERalpha, but in ERbeta expressing system the effectiveness remains on a statistically significant level, demonstrating an "exclusive ERbeta-selectivity" in U2OS human osteosarcoma cells, and therefore 7 can be considered as an isotype-selective ER ligand. Finally all the tested isoflavones derivatives appear to exhibit a slightly pronounced ERbeta preference, depending upon the position and the nature of the substituent moiety on the isoflavone skeleton. The estrogen-like effect of these prenylated isoflavone derivatives could be inhibited by the pure ER antagonist ICI 182 780, indicating that these effects were primarily mediated through ERs.


Subject(s)
Erythrina/chemistry , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/metabolism , Isoflavones/chemistry , Isoflavones/pharmacology , Cell Line, Tumor , Estrogen Receptor alpha/genetics , Estrogen Receptor beta/genetics , Genes, Reporter , Genistein/chemistry , Genistein/isolation & purification , Genistein/pharmacology , Humans , Isoflavones/isolation & purification , Osteosarcoma/genetics , Osteosarcoma/metabolism , Prenylation , Structure-Activity Relationship , Transfection
16.
J Nat Prod ; 72(9): 1603-7, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19705860

ABSTRACT

Five new isoflavones, named 5,4'-dihydroxy-7-methoxy-3'-(3-methylbuten-2-yl)isoflavone (1), 5,2',4'-trihydroxy-7-methoxy-5'-(3-methylbuten-2-yl)isoflavone (2), 5,4'-dihydroxy-7-methoxy-3'-(3-methyl-2-hydroxybuten-3-yl)isoflavone (3), 3'-formyl-5,4'-dihydroxy-7-methoxyisoflavone (4), and 5-hydroxy-3''-hydroxy-2'',2''-dimethyldihydropyrano[5'',6'':3',4']isoflavone (5), as well as six known compounds, wighteone (6), 3'-isoprenylgenistein (7), isolupabigenin (8), alpinumisoflavone (9), erypoegin D (10), and crystacarpin (11), were isolated from Erythrina poeppigiana. The structures of the isolated compounds were elucidated on the basis of chemical and spectroscopic analysis. The affinity of these compounds for the estrogen receptors ERalpha and ERbeta was evaluated using a receptor binding assay. While isoprenyl and dimethylpyrano substituents in ring A reduced the affinity of binding to ERbeta ca. 100-fold compared to genistein, the isoprenyl substituent in ring B was better accommodated, allowing 7 to bind with ca. 10-fold lower affinity than genistein.


Subject(s)
Erythrina/chemistry , Estrogen Receptor alpha/drug effects , Estrogen Receptor beta/drug effects , Isoflavones/isolation & purification , Bolivia , Genistein/pharmacology , Humans , Isoflavones/chemistry , Isoflavones/pharmacology , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Plant Bark/chemistry , Plant Stems/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...